Risk factors that attenuate the female coronary disease advantage
- PMID: 7802521
Risk factors that attenuate the female coronary disease advantage
Abstract
Objective: To compare the coronary disease experience of men and women in a community setting.
Design and setting: Prospective cohort study.
Patients: Long-term follow-up of a population-based sample of 5209 men and women.
Results: Women outlive men and experience fewer cardiovascular events. By middle age, women lag 20 years behind men in the incidence of myocardial infarction, but the gap closes in the elderly, when cardiovascular disease becomes the leading cause of death in women as well as in men. Menopause promptly escalates coronary disease risk threefold and greatly erodes the advantage over men. Women and men share the same major risk factors for coronary disease, although women experience a lower absolute risk. However, high ratios of total/high-density lipoprotein cholesterol level ratios, left ventricular hypertrophy, and diabetes tend to eliminate the female advantage.
Conclusion: Coronary disease is not a minor problem in women. Consequently, women should take vigorous preventive measures. There is a need for particular attention to glucose tolerance and blood lipid levels and a greater sense of urgency when hypertension progresses to left ventricular hypertrophy.
Similar articles
-
The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.J Gend Specif Med. 2002 Mar-Apr;5(2):27-37. J Gend Specif Med. 2002. PMID: 11974672 Review.
-
Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.J Cardiovasc Risk. 2002 Apr;9(2):67-76. J Cardiovasc Risk. 2002. PMID: 12006913
-
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.Can J Cardiol. 1997 Mar;13(3):253-60. Can J Cardiol. 1997. PMID: 9117913
-
The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.Can J Cardiol. 1999 Apr;15(4):419-27. Can J Cardiol. 1999. PMID: 10322251
-
[Cardiovascular risk factors and prevention in women: similarities and differences].Ital Heart J Suppl. 2001 Feb;2(2):125-41. Ital Heart J Suppl. 2001. PMID: 11255880 Review. Italian.
Cited by
-
Estimated incidence and risk factors of sudden unexpected death.Open Heart. 2016 Mar 23;3(1):e000321. doi: 10.1136/openhrt-2015-000321. eCollection 2016. Open Heart. 2016. PMID: 27042316 Free PMC article.
-
OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention.Diagnostics (Basel). 2020 Nov 20;10(11):976. doi: 10.3390/diagnostics10110976. Diagnostics (Basel). 2020. PMID: 33233550 Free PMC article. Review.
-
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia. 2022 Dec;65(12):1925-1966. doi: 10.1007/s00125-022-05787-2. Epub 2022 Sep 24. Diabetologia. 2022. PMID: 36151309 Free PMC article. Review.
-
Managing mixed dyslipidemia in special populations.Prev Cardiol. 2010 Spring;13(2):78-83. doi: 10.1111/j.1751-7141.2009.00057.x. Prev Cardiol. 2010. PMID: 20377810 Free PMC article. Review.
-
Abnormal lipid profile and hyperinsulinaemia after a mixed meal: additional cardiovascular risk factors in young adults born preterm.Diabetologia. 2008 Jul;51(7):1269-75. doi: 10.1007/s00125-008-1029-5. Epub 2008 May 22. Diabetologia. 2008. PMID: 18496668
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous